Taconic Biosciences Archives

Home / Posts tagged Taconic Biosciences

Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment

RENSSELAER, N.Y., Oct. 24 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolv™ NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors (FcγRs) known to confound results in antibody-based therapy studies. Murine FcγRs can cause false positives or [...]

Taconic Biosciences Appoints Nomura Siam as Distributor in India for All Taconic Animal Models

RENSSELAER, N.Y., May 10 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India. India makes a significant contribution to global pharmaceutical and vaccine production, and its [...]

Taconic Biosciences Improves rasH2 Carcinogenicity Test System Access in Asia-Pacific Region

RENSSELAER, N.Y., March 21 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd. (NSI) and Nomura Jimusho. Inc. (NJI) as sales agents and distributors of the rasH2 Mouse Carcinogenicity Test System in India and China, respectively. These distribution arrangements greatly improve rasH2 [...]

Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory

RENSSELAER, N.Y., Feb. 21 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, launched Cage+, a holistic, innovative approach to murine contract breeding services. Cage+ delivers complete stewardship of projects from start to finish, allowing investigators to focus on research with confidence that animal model supply is reliable, at [...]

Taconic Biosciences Adds New Humanized Immune System (HIS) Model to Its Portfolio for Immuno-Oncology Research

RENSSELAER, N.Y., Jan. 18 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse. This product expands Taconic’s widely used HIS portfolio. huNOG-EXL EA significantly lengthens the study window during which a myeloid-lineage HIS mouse model [...]

Taconic Biosciences Launches TruIMPORT™ Importation Solution

RENSSELAER, N.Y., May 27 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen Model Generation Alliance allowing seamless importation of new genetically engineered models originating in China under the TruIMPORT™ umbrella. Researchers at non-profit institutions play a critical role in drug discovery; [...]

Taconic Biosciences Launches New COVID-19 Mouse Model

RENSSELAER, N.Y., April 29 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit. In October 2020, Taconic launched its first hACE2 model. The AC70 mouse experiences a lethal response to [...]

Taconic Biosciences Expands Scientific Advisory Board

RENSSELAER, N.Y., March 15 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD. The SAB collaborates with Taconic management, providing scientific [...]

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

RENSSELAER, N.Y., Jan. 18 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body’s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role [...]

Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio

RENSSELAER, New York, Dec. 3 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random Integration Transgenic (RITg) service, which reduces animal model generation costs and timeline. Many gene editing technologies are used to generate animal models for drug discovery, each with unique considerations but with [...]